Molecular typing is predicated on molecular genetic testing and isn't yet routinely offered. Molecular subtypes and immunohistochemical surrogate markers in the tumors (HR, HER2, triple damaging) correlate in about 70%. The differentiation of luminal A and B subtypes by HR status and proliferation markers like Ki-67 could possibly be https://camillax096cnx8.nizarblog.com/profile